Search for Clinical Trial Results
Myositis - 160 Studies Found
Status | Study |
Recruiting |
Study Name: Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis Condition: Dermatomyositis Date: 2015-06-02 Interventions:
|
Terminated |
Study Name: A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis Condition: Dermatomyositis Date: 2010-04-06 Interventions: Drug: Apremilast Apremilast 20mg PO BID |
Terminated |
Study Name: Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis Condition: Juvenile Dermatomyositis Date: 2006-05-09 Interventions:
|
Recruiting |
Study Name: Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) Condition: Dermatomyositis Date: 2016-03-11 Interventions:
|
Completed |
Study Name: Acthar in Treatment of Refractory Dermatomyositis and Polymyositis Condition:
Date: 2013-07-05 Interventions: Drug: Adrenocorticotropic Hormone Gel H.P. Acthar Gel 80 units will be self-administered subcutaneously |
Completed |
Study Name: A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis Condition: DERMATOMYOSITIS OR POLYMYOSITIS Date: 2007-09-20 Interventions:
|
Recruiting |
Study Name: Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis Condition:
Date: 2014-01-17 Interventions:
|
Completed |
Study Name: Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) Condition:
Date: 2006-06-08 Interventions:
|
Enrolling by invitation |
Study Name: Dermatomyositis and Polymyositis Registry Condition:
Date: 2012-07-06 Interventions: Drug: Acthar Physicians will prescribe Acthar at their own discretion; however the recommended dose is 8 |
Completed |
Study Name: Hand Function in Patients With Poly- or Dermatomyositis Condition:
Date: 2009-03-19 |